Apheresis to Treat Preeclampsia: Insights, Opportunities and Challenges

被引：5

作者：

Easterling, Thomas R. ^{[1
]}

机构：

[1] Univ Washington, Dept Obstet & Gynecol, 1959 Pacific St,Box 356460, Seattle, WA 98195 USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2016年 / 27卷 / 03期

关键词：

TYROSINE KINASE-1; PRAVASTATIN; RISK;

D O I：

10.1681/ASN.2015070794

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：663 / 665

页数：3

共 10 条

[1]

Abalos E, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002252.pub2, 10.1002/14651858.CD002252.pub3]

[2] Hemodynamically-Directed Atenolol Therapy is Associated with a Blunted Rise in Maternal sFLT-1 Levels During Pregnancy [J].

Carr, Darcy B. ;

Tran, Lan T. ;

Brateng, Debra A. ;

Kawamura, Cydney ;

Shofer, Jane B. ;

Karumanchi, S. Ananth ;

Easterling, Thomas R. .

HYPERTENSION IN PREGNANCY, 2009, 28 (01) :42-55

[3] Pravastatin for the Prevention of Preeclampsia in High-Risk Pregnant Women [J].

Costantine, Maged M. ;

Cleary, Kirsten .

OBSTETRICS AND GYNECOLOGY, 2013, 121 (02) :349-353

[4] Using Pravastatin to Improve the Vascular Reactivity in a Mouse Model of Soluble Fms-Like Tyrosine Kinase-1-Induced Preeclampsia [J].

Costantine, Maged M. ;

Tamayo, Esther ;

Lu, Fangxian ;

Bytautiene, Egle ;

Longo, Monica ;

Hankins, Gary D. V. ;

Saade, George R. .

OBSTETRICS AND GYNECOLOGY, 2010, 116 (01) :114-120

[5] Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia [J].

Fox, Karin A. ;

Longo, Monica ;

Tamayo, Esther ;

Kechichian, Talar ;

Bytautiene, Egle ;

Hankins, Gary D. V. ;

Saade, George R. ;

Costantine, Maged M. .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (04) :366.e1-366.e5

[6] Circulating angiogenic factors and the risk of preeclampsia [J].

Levine, RJ ;

Maynard, SE ;

Qian, C ;

Lim, KH ;

England, LJ ;

Yu, KF ;

Schisterman, EF ;

Thadhani, R ;

Sachs, BP ;

Epstein, FH ;

Sibai, BM ;

Sukhatme, VP ;

Karumanchi, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :672-683

[7] Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia [J].

Maynard, SE ;

Min, JY ;

Merchan, J ;

Lim, KH ;

Li, JY ;

Mondal, S ;

Libermann, TA ;

Morgan, LP ;

Sellke, FW ;

Stillman, IE ;

Epstein, FH ;

Sukhatme, VP ;

Karumanchi, SA .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :649-658

[8] Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta [J].

McMahon, Kerry ;

Karumanchi, S. Ananth ;

Stillman, Isaac E. ;

Cummings, Peter ;

Patton, Dorothy ;

Easterling, Thomas .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01)

[9] Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia [J].

Ramma, Wenda ;

Ahmed, Asif .

JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2014, 101 :153-160

[10] Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia [J].

Thadhani, Ravi ;

Hagmann, Henning ;

Schaarschmidt, Wiebke ;

Roth, Bernhard ;

Cingoez, Tuelay ;

Karunnanchi, S. Ananth ;

Wenger, Julia ;

Lucchesi, Kathryn J. ;

Tamez, Hector ;

Lindner, Tom ;

Fridman, Alexander ;

Thome, Ulrich ;

Kribs, Angela ;

Danner, Marco ;

Hamacher, Stefanie ;

Mallmann, Peter ;

Stepan, Holger ;

Benzing, Thomas .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (03) :903-913

← 1 →